11. Psychopharmacology in Pediatric Oncology

  1. Shulamith Kreitler5,6,7,
  2. Myriam Weyl Ben-Arush8,9 and
  3. Andrés Martin10,11
  1. Elizabeth G. Pinsky1 and
  2. Annah N. Abrams2,3,4

Published Online: 1 JUL 2012

DOI: 10.1002/9781119941033.ch11

Pediatric Psycho-Oncology: Psychosocial Aspects and Clinical Interventions, Second Edition

Pediatric Psycho-Oncology: Psychosocial Aspects and Clinical Interventions, Second Edition

How to Cite

Pinsky, E. G. and Abrams, A. N. (2012) Psychopharmacology in Pediatric Oncology, in Pediatric Psycho-Oncology: Psychosocial Aspects and Clinical Interventions, Second Edition (eds S. Kreitler, M. W. Ben-Arush and A. Martin), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781119941033.ch11

Editor Information

  1. 5

    School of Psychological Sciences, Tel-Aviv University, Israel

  2. 6

    Psychooncology Research Center, Sheba Medical Center, Tel Hashomer, Israel

  3. 7

    Faculty of Social Welfare and Health Sciences, University of Haifa, Israel

  4. 8

    Department of Pediatric Hematology Oncology, Meyer Children's Hospital, Israel

  5. 9

    Meyer Children's Hospital, Rambam Health Care Campus, Technion Israel-Institute of Technology, the Bruce Rappaport Faculty of Medicine, Haifa, Israel

  6. 10

    Child Study Center, Yale University School of Medicine, USA

  7. 11

    Smilow Cancer Hospital at Yale-New Haven, New Haven, CT, USA

Author Information

  1. 1

    Child and Adolescent Psychiatry Resident, Massachusetts General/McLean Hospital, MA, USA

  2. 2

    Department of Pediatric Hematology Oncology, Massachusetts General Hospital, Boston, MA, USA

  3. 3

    Child Psychiatry Consultation Liaison Service, Massachusetts General Hospital, Boston, MA, USA

  4. 4

    Harvard Medical School, Boston, MA, USA

Publication History

  1. Published Online: 1 JUL 2012
  2. Published Print: 27 JUL 2012

ISBN Information

Print ISBN: 9781119998839

Online ISBN: 9781119941033

SEARCH

Keywords:

  • child mental health;
  • oncology;
  • pediatric cancer;
  • pharmacologic interactions;
  • psychopharmacology

Summary

The last decades have brought increasing recognition of mental illness in all populations of children. There has been a concurrent increased recognition of the impact that mental illness can have on the health and wellbeing of children with medical illness and the impact that medical illness can have on a child's mental health. While pediatric psychopharmacology in the medically ill child lags behind evidence-based adult practices, there are nevertheless an expanding number of treatment options. Here we will explore pharmacologic considerations for children with cancer; these include psychiatric side effects of common non-psychoactive medications, psychoactive medications by indication, and pharmacologic interactions and adverse effects at the intersection of oncology and psychiatry.